Thermo Fisher Scientific
NEWS
Biopharma companies name new members of their leadership teams. Who made big moves this week?
Boston Business Journal recently created a list of 15 Massachusetts life science companies that in their third-quarter reports, allocated the highest percentage of total costs to research and development. Here’s a look.
In what appears to be a trend, big pharma company AbbVie is leasing 479,000 square feet of space inBioMed Realty’s Gateway of Pacific project in South San Francisco.
The two biggest areas for biotech startups in the U.S. are Cambridge in Boston and the San Francisco Bay Area. They’re also the locations of astonishingly expensive real estate. But they’re where biotechs seem to want to be because they’re close to talent, academic research institutions, and the attention of venture capital.
Massachusetts in general and Boston, specifically Cambridge, is one of the two largest centers in the U.S. for biotech startups and life science companies (the other being the San Francisco Bay Area). Here’s a look at 13 Massachusetts life science companies that are showing both gains and losses—mostly gains—at the six-month mark.
Boston-based startup Catalog is one of the companies leading the way in the development of commercially viable DNA data storage.
The difference between the salaries paid to top executives and the median income earned by rank and file employees has been a sore subject for many years and has served as a wedge political issue in recent elections.
Less than a week after unveiling its first cloud-enabled biological safety cabinet for contamination control, Thermo Fisher Scientific launched its first NGS panel that specifically targets mutations associated with pediatric and young adult cancers.
The two companies each have facilities in Puerto Rico due in part to the U.S. territory’s favorable corporate tax climate.
JOBS
IN THE PRESS